Research progress on the protective mechanism of a novel soluble epoxide hydrolase inhibitor TPPU on ischemic stroke

Arachidonic Acid (AA) is the precursor of cerebrovascular active substances in the human body, and its metabolites are closely associated with the pathogenesis of cerebrovascular diseases. In recent years, the cytochrome P450 (CYP) metabolic pathway of AA has become a research hotspot. Furthermore,...

Full description

Bibliographic Details
Main Author: Pan Huang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Neurology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2023.1083972/full
_version_ 1828039464177369088
author Pan Huang
author_facet Pan Huang
author_sort Pan Huang
collection DOAJ
description Arachidonic Acid (AA) is the precursor of cerebrovascular active substances in the human body, and its metabolites are closely associated with the pathogenesis of cerebrovascular diseases. In recent years, the cytochrome P450 (CYP) metabolic pathway of AA has become a research hotspot. Furthermore, the CYP metabolic pathway of AA is regulated by soluble epoxide hydrolase (sEH). 1-trifluoromethoxyphenyl-3(1-propionylpiperidin-4-yl) urea (TPPU) is a novel sEH inhibitor that exerts cerebrovascular protective activity. This article reviews the mechanism of TPPU's protective effect on ischemic stroke disease.
first_indexed 2024-04-10T16:41:25Z
format Article
id doaj.art-c3ff9938ffa84e5d920de46454d60b80
institution Directory Open Access Journal
issn 1664-2295
language English
last_indexed 2024-04-10T16:41:25Z
publishDate 2023-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neurology
spelling doaj.art-c3ff9938ffa84e5d920de46454d60b802023-02-08T07:02:37ZengFrontiers Media S.A.Frontiers in Neurology1664-22952023-02-011410.3389/fneur.2023.10839721083972Research progress on the protective mechanism of a novel soluble epoxide hydrolase inhibitor TPPU on ischemic strokePan HuangArachidonic Acid (AA) is the precursor of cerebrovascular active substances in the human body, and its metabolites are closely associated with the pathogenesis of cerebrovascular diseases. In recent years, the cytochrome P450 (CYP) metabolic pathway of AA has become a research hotspot. Furthermore, the CYP metabolic pathway of AA is regulated by soluble epoxide hydrolase (sEH). 1-trifluoromethoxyphenyl-3(1-propionylpiperidin-4-yl) urea (TPPU) is a novel sEH inhibitor that exerts cerebrovascular protective activity. This article reviews the mechanism of TPPU's protective effect on ischemic stroke disease.https://www.frontiersin.org/articles/10.3389/fneur.2023.1083972/fullTPPUischemic strokeblood-brain barrierischemia reperfusionarachidonic acid
spellingShingle Pan Huang
Research progress on the protective mechanism of a novel soluble epoxide hydrolase inhibitor TPPU on ischemic stroke
Frontiers in Neurology
TPPU
ischemic stroke
blood-brain barrier
ischemia reperfusion
arachidonic acid
title Research progress on the protective mechanism of a novel soluble epoxide hydrolase inhibitor TPPU on ischemic stroke
title_full Research progress on the protective mechanism of a novel soluble epoxide hydrolase inhibitor TPPU on ischemic stroke
title_fullStr Research progress on the protective mechanism of a novel soluble epoxide hydrolase inhibitor TPPU on ischemic stroke
title_full_unstemmed Research progress on the protective mechanism of a novel soluble epoxide hydrolase inhibitor TPPU on ischemic stroke
title_short Research progress on the protective mechanism of a novel soluble epoxide hydrolase inhibitor TPPU on ischemic stroke
title_sort research progress on the protective mechanism of a novel soluble epoxide hydrolase inhibitor tppu on ischemic stroke
topic TPPU
ischemic stroke
blood-brain barrier
ischemia reperfusion
arachidonic acid
url https://www.frontiersin.org/articles/10.3389/fneur.2023.1083972/full
work_keys_str_mv AT panhuang researchprogressontheprotectivemechanismofanovelsolubleepoxidehydrolaseinhibitortppuonischemicstroke